Glutathione

Producers shown on SFDA

(Record date:13/09/2021）

Producers shown on EP

(Quoted from EP website；record date:13/09/2021）

The company covers an area of 276 mu. At present, 60 t / A and 200 t / a glutathione projects have been completed, with a total area of 66000m2, a workshop building area of 15000 m2 and a warehouse area of 4000 m2.

The company's products have been certified by FDA of the United States, jdmf of Japan, KFDA of Korea, DCGI of India, koher and Halal halal halal food respectively. The quality meets the requirements of Pharmacopoeia standards of advanced countries such as Europe, the United States and Japan, and the quality and technical indicators are at the international leading level.

Producer:Yunnan Jida Biotechnology Co., Ltd., a subsidiary of Kunming Jida Pharmaceutical Co., Ltd., was established in 2008. The company's reduced glutathione (GSH) construction project covers an area of 60 mu. The construction site is located in Zhuangdian natural medicine area of Chuxiong Industrial Park, Yunnan, with a total construction area of about 17000 square meters. It is planned to build three workshops (fermentation workshop, crude extraction workshop, yeast drying workshop and refining workshop).

Producer:Zhejiang Hisun Pharmaceutical Co., Ltd. was founded in 1956. In 2000, Hisun issued A-shares in Shanghai stock exchange, but it continues to remain a state-owned enterprise. Hisun is one of the largest antibiotics and anti-tumor drug production bases in the country. It has won several titles, including first batch of innovative enterprises, national technology innovation demonstration enterprises, and "National Industrial Brand Demonstration Enterprise” of the Chinese Ministry of Industry and Information Technology. 

Hisun began as a small chemical factory and entered the pharmaceutical field in the early 1970s. Since its founding over 60 years ago in 1956, Hisun has amassed a total asset worth of 21.8 billion RMB. While Hisun is primarily engaged in the R&D, manufacturing, and sales and marking of API and final dosage forms of chemical and biological drugs, its core business has extended to include branded generic drugs, biosimilarst and other innovative drugs. 

Staff size:About 9000 persns

Registered capital:RMB 1 billion 169 million